acetylcarnitine has been researched along with Kidney Failure, Chronic in 6 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "End-stage renal disease (ESRD) patients undergoing hemodialysis treatment have reduced plasma L-carnitine levels; however, the relationship between dialysis age and carnitine status is poorly understood." | 1.32 | Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. ( Elias, T; Evans, AM; Faull, RJ; Fornasini, G; Nation, RL; Prasad, S; Reuter, SE, 2004) |
| "L-Carnitine is an endogenous molecule involved in fatty acid metabolism." | 1.31 | Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. ( Evans, AM; Faull, R; Fornasini, G; Lemanowicz, EF; Longo, A; Nation, RL; Pace, S, 2000) |
| " The predialysis and postdialysis plasma levels of L-carnitine decreased once dosing was ceased but had not returned to pretreatment levels after 6 weeks." | 1.31 | Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. ( Evans, AM; Faull, R; Fornasini, G; Lemanowicz, EF; Longo, A; Nation, RL; Pace, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, AM | 2 |
| Faull, RJ | 1 |
| Nation, RL | 2 |
| Prasad, S | 1 |
| Elias, T | 1 |
| Reuter, SE | 1 |
| Fornasini, G | 2 |
| Weinhandl, ED | 1 |
| Rao, M | 1 |
| Gilbertson, DT | 1 |
| Collins, AJ | 1 |
| Pereira, BJ | 1 |
| Albertazzi, A | 1 |
| Capelli, P | 1 |
| Di Paolo, B | 1 |
| Pola, P | 1 |
| Tondi, P | 1 |
| Vaccario, O | 1 |
| Faull, R | 1 |
| Lemanowicz, EF | 1 |
| Longo, A | 1 |
| Pace, S | 1 |
| Wanner, C | 1 |
| Hörl, WH | 1 |
| Kohse, KP | 1 |
| Dech, E | 1 |
| Rössle, C | 1 |
| Franz, HE | 1 |
| Fürst, P | 1 |
6 other studies available for acetylcarnitine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Carnitine; Female; Humans; Kidney Failure, Chronic; Male; | 2004 |
Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Algorithms; Child; Comorbidity; Female; Hospitalization; H | 2007 |
Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Carnitine; Cholesterol; Cholesterol, HDL; Female; Hormones | 1983 |
Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Topics: Acetylcarnitine; Adult; Aged; Analysis of Variance; Area Under Curve; Carnitine; Chromatography, Hig | 2000 |
Potential role of carnitine in patients with renal insufficiency.
Topics: Acetylcarnitine; Carnitine; Carnitine O-Palmitoyltransferase; Creatinine; Humans; Hyperlipidemias; K | 1986 |
The influence of kidney transplantation on carnitine metabolism.
Topics: Acetylcarnitine; Biological Availability; Carnitine; Creatinine; Evaluation Studies as Topic; Female | 1988 |